ANVS Competitors & Alternatives
Compare Annovis Bio, Inc. with similar stocks in the same industry
PHARMACEUTICAL PREPARATIONS
ANVS
Main Stock$2.60
Tradestie Score
48
Market Cap
$41.51M
Analyst Upside
+428.8%
Top Competitors
553 stocks in PHARMACEUTICAL PREPARATIONS| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
LLY
Eli Lilly & Co.
|
$1003.46
|
$739.95B | 51.3 | 58 | Compare |
|
JNJ
Johnson & Johnson
|
$233.10
|
$448.07B | 20.9 | 65 | Compare |
|
ABBV
ABBVIE INC.
|
$225.66
|
$431.71B | 169.7 | 62 | Compare |
|
NVO
Novo-Nordisk A/S
|
$50.30
|
$262.92B | 15.9 | 50 | Compare |
|
AZN
AstraZeneca PLC
|
$184.32
|
$261.56B | 62.6 | 61 | Compare |
|
NVS
Novartis AG
|
$149.86
|
$254.99B | 20.7 | 67 | Compare |
|
ABT
Abbott Laboratories
|
$109.02
|
$232.30B | 29.4 | 62 | Compare |
|
MRK
Merck & Co., Inc.
|
$115.84
|
$225.13B | 15.0 | 66 | Compare |
|
PFE
Pfizer Inc.
|
$25.77
|
$154.70B | 15.5 | 66 | Compare |
|
SNY
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
|
$47.49
|
$121.27B | 19.7 | 57 | Compare |
More ANVS Analysis
Data updated: Feb 04, 2026 | Industry: PHARMACEUTICAL PREPARATIONS (SIC 2834)
553 stocks in this industry